Milestone Scientific, Inc. (MLSS): Price and Financial Metrics
MLSS Price/Volume Stats
| Current price | $0.87 | 52-week high | $1.35 |
| Prev. close | $0.86 | 52-week low | $0.41 |
| Day low | $0.83 | Volume | 136,400 |
| Day high | $0.91 | Avg. volume | 84,611 |
| 50-day MA | $0.88 | Dividend yield | N/A |
| 200-day MA | $0.92 | Market Cap | 61.81M |
MLSS Stock Price Chart Interactive Chart >
MLSS Stock Summary
- MLSS's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 181.37 -- higher than 85.05% of US-listed equities with positive expected earnings growth.
- For MLSS, its debt to operating expenses ratio is greater than that reported by merely 8.02% of US equities we're observing.
- With a price/sales ratio of 5.44, MILESTONE SCIENTIFIC INC has a higher such ratio than 83.25% of stocks in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to MILESTONE SCIENTIFIC INC are HNST, SNOA, SONM, SPWR, and SIBN.
- Visit MLSS's SEC page to see the company's official filings. To visit the company's web site, go to www.milestonescientific.com.
MLSS Valuation Summary
- In comparison to the median Healthcare stock, MLSS's price/sales ratio is 69.44% higher, now standing at 6.1.
- MLSS's price/sales ratio has moved down 0.5 over the prior 243 months.
Below are key valuation metrics over time for MLSS.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| MLSS | 2023-11-03 | 6.1 | 7.7 | -8.2 | -7.6 |
| MLSS | 2023-11-02 | 6.2 | 7.7 | -8.2 | -7.7 |
| MLSS | 2023-11-01 | 6.2 | 7.8 | -8.3 | -7.7 |
| MLSS | 2023-10-31 | 6.3 | 7.8 | -8.3 | -7.8 |
| MLSS | 2023-10-30 | 6.4 | 8.1 | -8.6 | -8.0 |
| MLSS | 2023-10-27 | 6.4 | 8.0 | -8.5 | -7.9 |
MLSS Growth Metrics
- Its 5 year cash and equivalents growth rate is now at -73.96%.
- Its 5 year net income to common stockholders growth rate is now at -50.8%.
- Its year over year revenue growth rate is now at 53.89%.
The table below shows MLSS's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 9.411002 | -3.221857 | -7.85378 |
| 2022-06-30 | 9.303536 | -4.135996 | -7.925184 |
| 2022-03-31 | 10.08091 | -4.557275 | -7.747171 |
| 2021-12-31 | 10.30471 | -4.017581 | -6.818317 |
| 2021-09-30 | 9.670744 | -6.376852 | -6.776149 |
| 2021-06-30 | 8.808621 | -6.556074 | -6.223931 |
MLSS's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- MLSS has a Quality Grade of C, ranking ahead of 36.73% of graded US stocks.
- MLSS's asset turnover comes in at 0.423 -- ranking 112th of 186 Medical Equipment stocks.
- TNDM, TFX, and PEN are the stocks whose asset turnover ratios are most correlated with MLSS.
The table below shows MLSS's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-06-30 | 0.423 | 0.616 | -2.177 |
| 2021-03-31 | 0.315 | 0.637 | -2.538 |
| 2020-12-31 | 0.325 | 0.666 | -3.651 |
| 2020-09-30 | 0.411 | 0.683 | -7.765 |
| 2020-06-30 | 0.616 | 0.698 | 30.088 |
| 2020-03-31 | 1.274 | 0.690 | 6.927 |
Milestone Scientific, Inc. (MLSS) Company Bio
Milestone Scientific Inc. operates as a medical technology company. The Company manufactures, markets, and sells computer-controlled local anesthetic delivery systems for plastic surgery, podiatry, dermatology, and orthopedics. Milestone Scientific serves medical sector worldwide.
Latest MLSS News From Around the Web
Below are the latest news stories about MILESTONE SCIENTIFIC INC that investors may wish to consider to help them evaluate MLSS as an investment opportunity.
Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023Reports 45% increase in domestic sales for the third quarter of 2023;new online store providing greater interaction with dentists and improved margins Gross profit margin increases to 73% for the third quarter of 2023, compared to 66% for the same period last year Medical division reports expansion of sales in a prominent hospital system, and pain management clinics Reports progress advancing reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., Nov. 15, 2023 (GLOBE NEWSWIRE) |
Milestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference CallROSELAND, N.J., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, November 15, 2023, to discuss the company’s financial results for the third quarter ended September 30, 2023, as well as the company’s corporate progress and other developments. The conference call will be availa |
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New YorkRepresents first sales by the Company into an ambulatory surgery center Follows successful evaluation by Island Ambulatory Surgery Center’s founder and medical director, Dr. Leon Reyfman, reporting 100% success ROSELAND, N.J., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it has commenced sales of CompuFlo® Epidural disposables into Island Am |
Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of DirectorsROSELAND, N.J., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced the appointment of Dr. Didier Demesmin, MD, MBA, to the Board of Directors. Dr. Demesmin is an interventional pain medicine physician who is double board-certified in both anesthesiology and pain medicine. He is the founder of University Pain and Spine center, a well-respected interve |
Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023Gross profit increases 178% compared to the same period last year New online store providing greater interaction with dentists and improved margins Medical division reports positive reimbursement from first commercial payers ROSELAND, N.J., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the seco |
MLSS Price Returns
| 1-mo | -3.33% |
| 3-mo | -18.69% |
| 6-mo | -16.35% |
| 1-year | 40.32% |
| 3-year | -50.29% |
| 5-year | 64.15% |
| YTD | 81.25% |
| 2022 | -76.70% |
| 2021 | -2.83% |
| 2020 | 52.52% |
| 2019 | 318.67% |
| 2018 | -71.86% |
Continue Researching MLSS
Want to do more research on Milestone Scientific Inc's stock and its price? Try the links below:Milestone Scientific Inc (MLSS) Stock Price | Nasdaq
Milestone Scientific Inc (MLSS) Stock Quote, History and News - Yahoo Finance
Milestone Scientific Inc (MLSS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...